FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029683890> ?p ?o ?g. }

• W2029683890 endingPage "12520" @default.
• W2029683890 startingPage "12516" @default.
• W2029683890 abstract "Substrate binding and the subsequent reaction are the two principal phenomena that underlie the activity of enzymes, and many enzyme-like catalysts were generated based on the phenomena. The single chain variable region fragment of antibody 2F3 (scFv2F3) was elicited against hapten GSH-S-DN2phBu, a conjugate of glutathione (GSH), butyl alcohol, and 1-chloro-2,4-dinitrobenzene (CDNB); it can therefore bind both GSH and CDNB, the substrates of native glutathione S-transferases (GSTs). It was shown previously that there is a serine residue that is the catalytic group of GST in the CDR regions of scFv2F3 close to the sulfhydryl of GSH. Thus, we anticipated that scFv2F3 will display GST activity. The experimental results showed that scFv2F3 indeed displayed GST activity that is equivalent to the rat θ-class GST T-2-2 and exhibited pH- and temperature-dependent catalytic activity. Steady-state kinetic studies showed that the Km values for the substrates are close to those of native GSTs, indicating that scFv2F3 has strong affinities for the substrates. Compared with some other GSTs, its kcat value was found to be low, which could be caused by the similarity between the GSH-S-DN2phBu and the reaction product of GSH and CDNB. These results showed that our approach to imitating enzymes is correct, which is that an active site may catalyze a chemical reaction when a catalytic group locates beside a substrate-binding site of a receptor. It is important to consider product inhibition in hapten design in order to obtain a mimic with a high catalytic efficiency. Substrate binding and the subsequent reaction are the two principal phenomena that underlie the activity of enzymes, and many enzyme-like catalysts were generated based on the phenomena. The single chain variable region fragment of antibody 2F3 (scFv2F3) was elicited against hapten GSH-S-DN2phBu, a conjugate of glutathione (GSH), butyl alcohol, and 1-chloro-2,4-dinitrobenzene (CDNB); it can therefore bind both GSH and CDNB, the substrates of native glutathione S-transferases (GSTs). It was shown previously that there is a serine residue that is the catalytic group of GST in the CDR regions of scFv2F3 close to the sulfhydryl of GSH. Thus, we anticipated that scFv2F3 will display GST activity. The experimental results showed that scFv2F3 indeed displayed GST activity that is equivalent to the rat θ-class GST T-2-2 and exhibited pH- and temperature-dependent catalytic activity. Steady-state kinetic studies showed that the Km values for the substrates are close to those of native GSTs, indicating that scFv2F3 has strong affinities for the substrates. Compared with some other GSTs, its kcat value was found to be low, which could be caused by the similarity between the GSH-S-DN2phBu and the reaction product of GSH and CDNB. These results showed that our approach to imitating enzymes is correct, which is that an active site may catalyze a chemical reaction when a catalytic group locates beside a substrate-binding site of a receptor. It is important to consider product inhibition in hapten design in order to obtain a mimic with a high catalytic efficiency. The generation of enzyme-like catalysts continues to be a fundamental goal for biochemists. Imitation of enzymes is helpful not only for understanding how enzymes work but also for obtaining practical catalysts. Natural enzymes catalyze biochemical reactions by binding one or two small molecules into an active site, with a catalytic group held nearby so as to interact effectively with the bound substrate molecule. Therefore, our opinion is that an active site may catalyze a chemical reaction when a catalytic group locates near a substrate-binding site of a receptor. Moreover, we have developed an approach to imitate enzymes, based on introducing a catalytic group into a receptor with a substrate-binding site to create an active site capable of catalyzing a chemical reaction. The ability to create novel active sites in this way permits us to systematically explore the basic principles of biological catalysis and to evaluate alternative catalytic pathways for particular reactions by comparing with native enzymes. So far, we have successfully generated some mimics with high glutathione peroxidase (GPX) 2The abbreviations used are: GPX, glutathione peroxidase; CDNB, 1-chloro-2,4-dinitrobenzene; GSH, glutathione; scFv, single chain variable region fragments of antibodies; Se-scFv, selenium-containing scFv; GSH-S-DN2phBu, GSH-dinitrophenyl butinyl ester; GST, glutathione S-transferase; rGST T2-2, rat θ-class GST T-2-2; CuOOH, cumene hydroperoxide. activity by this approach (1Sun Y. Li T.Y. Chen H. Zhang K. Zheng K.Y. Mu Y. Yan G.L. Li W. Shen J.C. Luo G.M. J. Biol. Chem. 2004; 279: 37235-37240Abstract Full Text Full Text PDF PubMed Scopus (43) Google Scholar, 2Liu J.Q. Zhang K. Ren X.J. Luo G.M. Shen J.C. Anal. Chim. Acta. 2004; 504: 185-189Crossref Scopus (30) Google Scholar, 3Zhang K. Ren X.J. Mu Y. Xue Y. Guo C.H. Yan G.L. Luo G.M. Shen J.C. Chin. J. Catal. 2003; 24: 97-102Google Scholar, 4Ren X.J. Jemth P. Board P.G. Luo G.M. Mannervik B. Liu J.Q. Zhang K. Shen J.C. Chem. Biol. 2002; 9: 789-794Abstract Full Text Full Text PDF PubMed Scopus (49) Google Scholar, 5Su D. Ren X.J. You D.L. Li D. Mu Y. Yan G.L. Zhang Y. Luo G.M. Xue Y. Shen J.C. Arch. Biochem. Biophys. 2001; 395: 177-184Crossref PubMed Scopus (37) Google Scholar, 6Ren X.J. Gao S.J. You D.L. Huang H.L. Liu Z. Mu Y. Liu J.Q. Zhang Y. Yan G.L. Luo G.M. Yang T.S. Shen J.C. Biochem. J. 2001; 359: 369-374Crossref PubMed Google Scholar, 7Ren X.J. Yang L.Q. Liu J.Q. Su D. You D.L. Liu C.P. Zhang K. Luo G.M. Mu Y. Yan G.L. Shen J.C. Arch. Biochem. Biophys. 2001; 387: 250-256Crossref PubMed Scopus (52) Google Scholar, 8Liu J.Q. Shi C.B. Luo G.M. Liu Z. Zhang G.L. Ma W.Y. Shen J.C. Mat. Sci. Eng. C. 1999; 10: 131-134Crossref Scopus (11) Google Scholar, 9Luo G.M. Zhu Z.Q. Ding L. Gao G. Sun Q. Liu Z. Yang T.S. Shen J.C. Biochem. Biophys. Res. Commun. 1994; 198: 1240-1247Crossref PubMed Scopus (72) Google Scholar, 10Luo G.M. Ding L. Liu Z. Yang T.S. Ni J.Z. Ann. N. Y. Acad. Sci. 1998; 864: 136-141Crossref PubMed Scopus (7) Google Scholar, 11Ding L. Liu Z. Zhu Z.Q. Luo G.M. Zhao D.Q. Ni J.Z. Biochem. J. 1998; 332: 251-255Crossref PubMed Scopus (77) Google Scholar). Glutathione S-transferases (GSTs, EC 2.5.1.18) are a superfamily of multifunctional enzymes involved in cellular detoxification by conjugating the tripeptide glutathione (GSH) to a wide range of endobiotic and xenobiotic electrophilic compounds (12Dirr H.W. Reinemer P. Huber R. Eur. J. Biochem. 1994; 220: 645-661Crossref PubMed Scopus (387) Google Scholar, 13Wilce M.C. Board P.G. Feil S.C. Parker M.W. EMBO J. 1995; 14: 2133-2143Crossref PubMed Scopus (218) Google Scholar, 14Armstrong R.N. Chem. Res. Toxicol. 1997; 10: 2-18Crossref PubMed Scopus (963) Google Scholar). According to sequence, immunological, kinetic, and tertiary/quaternary structural properties, GSTs are grouped in at least 10 independent classes (15Sheehan D. Meade G. Foley V.M. Dowd C.A. Biochem. J. 2001; 360: 1-16Crossref PubMed Scopus (1421) Google Scholar). In the active site of GSTs, the catalytic residue is typically either Tyr or Ser, presumed to act by inducing and stabilizing a reactive thiolate at the conjugating sulfur of the GSH substrate (14Armstrong R.N. Chem. Res. Toxicol. 1997; 10: 2-18Crossref PubMed Scopus (963) Google Scholar, 15Sheehan D. Meade G. Foley V.M. Dowd C.A. Biochem. J. 2001; 360: 1-16Crossref PubMed Scopus (1421) Google Scholar). To generate a substrate-binding site, one of the general strategies is standard monoclonal antibody preparation technique because the characteristic binding specificity of antibodies offers mimics the potential for unique substrate selectivity. The single chain variable region fragment of antibody (scFv) is a recombinant polypeptide consisting of a heavy chain variable region and a light chain variable region joined by a short peptide linker. It is the smallest antibody fragment that consistently maintains the binding specificity and affinity of the whole antibody (16Glockshuber R. Malia M. Pfitzinger I. Pluckthun A. Biochemistry. 1990; 29: 1362-1367Crossref PubMed Scopus (454) Google Scholar). The monoclonal antibody 2F3 was elicited against the hapten GSH-S-DN2phBu, which is a conjugate of GSH, butyl alcohol, and 1-chloro-2,4-dinitrobenzene (CDNB) (5Su D. Ren X.J. You D.L. Li D. Mu Y. Yan G.L. Zhang Y. Luo G.M. Xue Y. Shen J.C. Arch. Biochem. Biophys. 2001; 395: 177-184Crossref PubMed Scopus (37) Google Scholar). The single chain antibody scFv2F3, whose amino acid sequence is shown in Fig. 1, was obtained from monoclonal antibody 2F3 (6Ren X.J. Gao S.J. You D.L. Huang H.L. Liu Z. Mu Y. Liu J.Q. Zhang Y. Yan G.L. Luo G.M. Yang T.S. Shen J.C. Biochem. J. 2001; 359: 369-374Crossref PubMed Google Scholar). Therefore, it can bind both GSH (17Su D. You D.L. Ren X.J. Luo G.M. Mu Y. Yan G.L. Xue Y. Shen J.C. Biochem. Biophys. Res. Commun. 2001; 285: 702-707Crossref PubMed Scopus (7) Google Scholar) and CDNB, which are substrates of native GSTs (Scheme 1). It was further converted to selenium-containing scFv2F3 (Se-scFv2F3) by chemical mutation (6Ren X.J. Gao S.J. You D.L. Huang H.L. Liu Z. Mu Y. Liu J.Q. Zhang Y. Yan G.L. Luo G.M. Yang T.S. Shen J.C. Biochem. J. 2001; 359: 369-374Crossref PubMed Google Scholar). Molecular dynamics simulation studies of Se-scFv2F3 show that the chemical modification site of Se-scFv2F3 is SerH52, which is close to the sulfhydryl of GSH (18Zhang Y. Li Z.S. Sun M. Zheng Q.C. Sun C.C. Biochim. Biophys. Acta. 2005; 1747: 27-34Crossref PubMed Scopus (12) Google Scholar). Thus, we anticipate the single chain antibody would display GST activity because it has both a substrate-binding site and a potentially catalytic group, which are collocated properly. Here we have reported the enzymic properties and kinetic behaviors of the scFv2F3 and discussed the importance of Ser as the catalytic residue of scFv2F3, as well as product inhibition and hapten design.SCHEME 1The reaction of glutathione S-transferase catalyzing GSH conjugated to CDNB.View Large Image Figure ViewerDownload Hi-res image Download (PPT) Materials—CDNB and cumene hydroperoxide (CuOOH) were obtained from Sigma. Glutathione reductase (type III baker's yeast) was obtained from Roche Applied Science. NADPH was purchased from Roche Applied Science. Reduced glutathione and 1-bromo-4-nitrobenzene were obtained from Aldrich. All other reagents were of analytic grade. Preparation of scFv2F3—ScFv2F3 was expressed in Escherichia coli and purified as described previously (6Ren X.J. Gao S.J. You D.L. Huang H.L. Liu Z. Mu Y. Liu J.Q. Zhang Y. Yan G.L. Luo G.M. Yang T.S. Shen J.C. Biochem. J. 2001; 359: 369-374Crossref PubMed Google Scholar). Briefly, monoclonal 2F3 was elicited against the hapten (5Su D. Ren X.J. You D.L. Li D. Mu Y. Yan G.L. Zhang Y. Luo G.M. Xue Y. Shen J.C. Arch. Biochem. Biophys. 2001; 395: 177-184Crossref PubMed Scopus (37) Google Scholar). Its VH and VL genes were cloned and sequenced from hybridoma 2F3 and used to construct the scFv2F3 by protein engineering. Assay of Enzyme Activities—The specific activities of GST toward CDNB and 1-bromo-4-nitrobenzene were measured according to published methods (19Habig W.H. Jakoby W.B. Methods Enzymol. 1981; 77: 398-405Crossref PubMed Scopus (2081) Google Scholar). The activity of GST toward CDNB was measured in 50 mm potassium phosphate buffer (pH 6.5) containing 1 mm EDTA, 1 mm CDNB, and 1 mm GSH. The activity of GST toward 1-bromo-4-nitrobenzene was measured in 50 mm potassium phosphate buffer (pH 6.5) containing 1 mm EDTA, 0.1 mm 1-bromo-4-nitrobenzene, and 5 mm GSH. The reactions were conducted at 25 °C in a total volume of 0.7 ml. One unit of activity is defined as the amount of scFv2F3 that produces 1 μmol of product min-1 at 25 °C. The specific activity is expressed in μmol·min-1·mg-1 of protein. The GPX activities were assayed as described with the coupled assay by Wilson et al. (20Wilson S.R. Zucker P.A. Huang R.R.C. Spector A. J. Am. Chem. Soc. 1989; 111: 5936-5939Crossref Scopus (409) Google Scholar). The reactions were carried out in a total volume of 0.7 ml of 50 mm potassium phosphate buffer (pH 7.0) containing 1 mm EDTA, 1 mm sodium azide, 1 mm GSH, 1 unit of GSH reductase, and 10-50 nm protein. The mixture was preincubated for 7 min. Then 0.25 mm NADPH solution was added, and the mixture was incubated for 3 min at 37 °C. Thereafter, the reaction was initiated by the addition of 0.5 mm H2O2 or 1.5 mm CuOOH. The activities were determined from the decrease of NADPH absorption at 340 nm. One unit of activity is defined as the amount of protein that catalyzes the turnover of 1 μmol NADPH/min. The specific activity is expressed in μmol·min-1·mg-1 of protein. The absorbance value was read on a UV-3100 spectrophotometer (Shimadzu). All initial rates were corrected for the background nonenzymatic reaction. The concentration of protein was determined by the method of Lowry et al. (21Lowry O.H. Rosebrough N.J. Farr A.L. Randall R.J. J. Biol. Chem. 1951; 193: 265-275Abstract Full Text PDF PubMed Google Scholar), with crystalline bovine serum albumin as a standard. The Mutation of Ser Residues in scFv2F3—Sodium hydroselenide was prepared according to the method described (22Klayman D.L. Griffin T.S. J. Am. Chem. Soc. 1973; 95: 197-199Crossref Scopus (602) Google Scholar). The mutation of Ser residues in scFv2F3 was performed according to Ref. 6Ren X.J. Gao S.J. You D.L. Huang H.L. Liu Z. Mu Y. Liu J.Q. Zhang Y. Yan G.L. Luo G.M. Yang T.S. Shen J.C. Biochem. J. 2001; 359: 369-374Crossref PubMed Google Scholar. Briefly, 0.5 mg of scFv2F3 was dissolved in 2 ml of 50 mm sodium phosphate buffer, pH 7.0; 20 μl of phenylmethylsulfonyl fluoride solution (20 mg/ml acetonitrile) was added and incubated for 3 h at room temperature. The sulfonylated scFv2F3 was flushed using pure nitrogen for 20 min and then treated with 10 μl of 1 m sodium hydroselenide for 36 h at 35 °C. The crude reaction mixture was purified first by centrifugation and then loaded on a Sephadex G-25 column and eluted with buffer (20 mm Tris/HCl, pH 8.0). The active fractions were pooled and finally freeze dried to obtain Se-scFv2F3. Determination of Optimal pH and Optimal Temperature for ScFv2F3 Catalysis—The optimal pH and optimal temperature of GST (CDNB) activity of scFv2F3 were measured with the same method as the GST (CDNB) activity assay. The initial rates were measured at the concentrations of 1 mm GSH and 1 mm CDNB. The pH value of buffer was changed in determining the initial rates of the reaction to obtain the optimal pH condition for scFv2F3-catalyzed reaction. Similarly, the optimal temperature for scFv2F3-catalyzed reaction was determined at different temperatures. Steady-state Kinetics of ScFv2F3—All kinetic experiments were performed in the same way as GST activity assay. The initial rates were measured by observing the increase of product absorption at 340 nm at several concentrations of one substrate while the concentration of the other substrate was fixed. GSH concentrations were varied from 0.1 to 1.0 mm; CDNB concentrations were also varied from 0.1 to 1.0 mm. The uncatalytic reaction affecting the measurement of the initial rate was taken into account and subtracted to obtain exact kinetic values. Kinetic data were analyzed by double reciprocal plotting. Enzyme Activities of ScFv2F3—Using CDNB and 1-bromo-4-nitrobenzene as substrates we assayed the GST activities of scFv2F3, which were found to be 0.997 and 3.646 units/mg, respectively, and equivalent to the rat θ-class GST T-2-2 (rGST T2-2). The GPX activity of scFv2F3 to CuOOH is 0.928 units/mg, but scFv2F3 did not exhibit GPX activity to H2O2. However, after scFv2F3 converted into Se-scFv2F3 by chemical mutation, Se-scFv2F3 did not display any GST activity but exhibited a high GPX activity to CuOOH or H2O2 (6Ren X.J. Gao S.J. You D.L. Huang H.L. Liu Z. Mu Y. Liu J.Q. Zhang Y. Yan G.L. Luo G.M. Yang T.S. Shen J.C. Biochem. J. 2001; 359: 369-374Crossref PubMed Google Scholar), as did rGST T2-2. Its GST activity toward CDNB was 0.9 units/mg, and its GPX activity to CuOOH was 2.1 units/mg, but it had no GPX activity to H2O2. After chemical mutation, rGST T2-2 was converted into Se-rGST T2-2. It then lost GST activity and gained a high GPX activity to CuOOH or H2O2 (4Ren X.J. Jemth P. Board P.G. Luo G.M. Mannervik B. Liu J.Q. Zhang K. Shen J.C. Chem. Biol. 2002; 9: 789-794Abstract Full Text Full Text PDF PubMed Scopus (49) Google Scholar). The GST and GPX activities of scFv2F3 as well as rGST T2-2 are listed in Table 1.TABLE 1The GST or GPX activities of scFv2F3 and other catalystsCatalystGST activityGPX activityCDNB1-Bromo-4-nitrobenzeneCuOOHH2O2units/mgscFv2F3aAll values are the means of at least five determinations0.9973.650.928NDbND, no detectable GST or GPX activitySe-scFv2F3aAll values are the means of at least five determinationsNDND27.46114[6]rGST T2–2cThe GST or GPX activities of rGST T2–2 and Se-rGST T2–2 are from Ref. 40.92.1NDSe-rGST T2–2cThe GST or GPX activities of rGST T2–2 and Se-rGST T2–2 are from Ref. 4ND23102a All values are the means of at least five determinationsb ND, no detectable GST or GPX activityc The GST or GPX activities of rGST T2–2 and Se-rGST T2–2 are from Ref. 4Ren X.J. Jemth P. Board P.G. Luo G.M. Mannervik B. Liu J.Q. Zhang K. Shen J.C. Chem. Biol. 2002; 9: 789-794Abstract Full Text Full Text PDF PubMed Scopus (49) Google Scholar Open table in a new tab Despite the diversity of substrates metabolized by this large family, CDNB is a relatively nonspecific GST reference substrate (23Gallagher E.P. Sheehy K.M. Lame M.W. Segall H.J. Environ. Toxicol. Chem. 2000; 19: 319-326Crossref Google Scholar), and GST (CDNB) activity reflects the integration of GST isoenzyme activities (24Hoarau P. Garello G. Gnassia-Barelli M. Romeo M. Girard J.P. Eur. J. Biochem. 2002; 269: 4359-4366Crossref PubMed Scopus (58) Google Scholar). To gauge the GST activity of scFv2F3, we compared in Table 2 the GST (CDNB) activity of scFv2F3 with those of some native GSTs that have been reported (4Ren X.J. Jemth P. Board P.G. Luo G.M. Mannervik B. Liu J.Q. Zhang K. Shen J.C. Chem. Biol. 2002; 9: 789-794Abstract Full Text Full Text PDF PubMed Scopus (49) Google Scholar, 24Hoarau P. Garello G. Gnassia-Barelli M. Romeo M. Girard J.P. Eur. J. Biochem. 2002; 269: 4359-4366Crossref PubMed Scopus (58) Google Scholar, 25Benson A.M. Talalay P. Keen J.H. Jakoby W.B. Proc. Natl. Acad. Sci. U. S. A. 1977; 74: 158-162Crossref PubMed Scopus (156) Google Scholar, 26Singh S.P. Coronella J.A. Benes H. Cochrane B.J. Zimniak P. Eur. J. Biochem. 2001; 268: 2912-2923Crossref PubMed Scopus (232) Google Scholar). The GST (CDNB) activity of scFv2F3 is much lower than that of some native GSTs that have been reported (24Hoarau P. Garello G. Gnassia-Barelli M. Romeo M. Girard J.P. Eur. J. Biochem. 2002; 269: 4359-4366Crossref PubMed Scopus (58) Google Scholar, 25Benson A.M. Talalay P. Keen J.H. Jakoby W.B. Proc. Natl. Acad. Sci. U. S. A. 1977; 74: 158-162Crossref PubMed Scopus (156) Google Scholar), but it is close to, even a little higher than, that of the others.TABLE 2GST (CDNB) activity of scFv2F3 compared with those of native GSTs Glutathione S-transferase activity with CDNB was measured in the presence of 50 mm potassium phosphate at pH 6.5, 1 mm GSH, 1 mm CDNB in ethanol (% (v/v) final concentration). Measurements were carried out at 340 nm (ϵ = 9.6 mm-1 cm-1) at 25 °C.ProteinGST (CDNB) activityRef.μmol·min/mg of proteinGST 3–3290.1724Hoarau P. Garello G. Gnassia-Barelli M. Romeo M. Girard J.P. Eur. J. Biochem. 2002; 269: 4359-4366Crossref PubMed Scopus (58) Google ScholarRat GST A6225Benson A.M. Talalay P. Keen J.H. Jakoby W.B. Proc. Natl. Acad. Sci. U. S. A. 1977; 74: 158-162Crossref PubMed Scopus (156) Google ScholarHuman GST α1925Benson A.M. Talalay P. Keen J.H. Jakoby W.B. Proc. Natl. Acad. Sci. U. S. A. 1977; 74: 158-162Crossref PubMed Scopus (156) Google ScholarDmGSTS1–10.4526Singh S.P. Coronella J.A. Benes H. Cochrane B.J. Zimniak P. Eur. J. Biochem. 2001; 268: 2912-2923Crossref PubMed Scopus (232) Google ScholarrGST T2–20.94Ren X.J. Jemth P. Board P.G. Luo G.M. Mannervik B. Liu J.Q. Zhang K. Shen J.C. Chem. Biol. 2002; 9: 789-794Abstract Full Text Full Text PDF PubMed Scopus (49) Google ScholarScFv2F30.997 Open table in a new tab The Optimal pH and Temperature for ScFv2F3-catalyzed Conjugation of GSH with CDNB—The GST (CDNB) activity of scFv2F3 was examined over the pH range from 4.5 to 11 and the temperature range from 15 to 60 °C (Fig. 2). For scFv2F3 catalyzing the conjugation of GSH with CDNB, the optimal pH was found to be 7.9 and the optimal temperature was found to be 44 °C. The GST (CDNB) activity of scFv2F3 at pH 6.5 is only 32.02% of that at pH 7.65. The activity of scFv2F3 at 25 °C is only 57.18% of that at 45 °C and at 60 °C only 5.58%. Above 55 °C it decreased rapidly, indicating that the structure of scFv2F3 is not steady under high temperatures. Steady-state Kinetics of ScFv2F3—The initial velocities catalyzed by scFv2F3 for the conjugation of GSH with CDNB were determined as a function of substrate concentration, varying one substrate concentration while the other was fixed. Double reciprocal plots of the initial velocity versus substrate concentration showed a family of convergent lines for both substrates. The results are shown in Fig. 3, and the apparent kinetic parameters are listed in Table 3. With the concentration of CDNB increased from 0.1 to 1.0 mm, the apparent Michaelis constant KmGSH increased little, only from 0.2752 to 0.3325 mm, but the first-order rate constant kcat increased obviously, from 5.604 to 41.77 min-1, and the apparent second-order constant kcat/KmGSH increased about one order of magnitude, from 20.36 to 125.9 mm-1 min-1 (see Table 3). The same changes happened to KmCDNB, kcat and kcat/KmCDNB while the concentrations of GSH increased. These parameters showed that the changes of substrate concentrations had almost no effect on Km but greatly affected kcat and kcat/Km.TABLE 3Apparent kinetic parameters for the GST (CDNB) activity of scFv2F3 Reactions were carried out in 50 mm potassium phosphate buffer, pH 6.5, at 25 °C. The data in the table were calculated from the plots in Fig. 2.CDNBkcatKmGSHkcat/KmGSHmmmin-1mmmm-1·min-10.10005.604 ± 0.0170.2752 ± 0.000820.36 ± 0.060.17149.887 ± 0.0490.2952 ± 0.001533.49 ± 0.170.250013.69 ± 0.0680.2996 ± 0.001545.70 ± 0.230.500023.70 ± 0.0320.3200 ± 0.000474.07 ± 0.101.00041.77 ± 0.0390.3325 ± 0.0003125.9 ± 0.12GSHkcatKm CDNBkcat/Km CDNBmmmmmm-1·min-10.100024.91 ± 0.591.570 ± 0.03715.86 ± 0.370.250045.62 ± 0.311.606 ± 0.01128.41 ± 0.190.500076.45 ± 0.712.000 ± 0.01938.23 ± 0.351.00095.42 ± 0.662.014 ± 0.01447.37 ± 0.33 Open table in a new tab The following Equation 1 for the reciprocal velocity accounts for these plots E0ν0=Φ0+ΦGSHGSH0+ΦCDNBCDNB0+ΦGSH-CDNBGSH0CDNB0(Eq. 1) where ν0 is the initial velocity of the enzymatic reaction, [E]0 is the total concentration of scFv2F3, and Φ0, ΦGSH, ΦCDNB, ΦGSH-CDNB are Dalziel parameters (27Dalziel K. Acta Chem. Scand. 1957; 11: 1706-1723Crossref Google Scholar), which are summarized in Table 4.TABLE 4Dalziel parameters of scFv2F3 catalyzed the conjugation of GSH with CDNBΦ0ΦGSHΦCDNBΦGSH-CDNBminmm·minmm2·min0.007290.003320.01660.00464 Open table in a new tab In Table 5, we compared the kinetic parameters for the GST (CDNB) activity of scFv2F3 with those of other native GSTs that have been reported (24Hoarau P. Garello G. Gnassia-Barelli M. Romeo M. Girard J.P. Eur. J. Biochem. 2002; 269: 4359-4366Crossref PubMed Scopus (58) Google Scholar, 28Caccuri A.M. Antonini G. Nicotra M. Battistoni A. Lo Bello M. Board P.G. Parker M.W. Ricci G. J. Biol. Chem. 1997; 272: 29681-29686Abstract Full Text Full Text PDF PubMed Scopus (70) Google Scholar). The KmGSH and KmCDNB of scFv2F3 are 0.4554 and 2.284 mm, respectively, and close to those of other native GSTs. But its kcat was only 2.286 s-1, much lower than those of the native GSTs.TABLE 5Kinetic parameters for the GST (CDNB) activity of scFv2F3 compared with those of native GSTs Steady-state kinetics of scFv2F3 were measured at 340 nm at 25°C as previously reported. Kinetic experiments were carried out in 0.7 ml (final volume) of 50 mm potassium phosphate buffer (pH 6.5) containing 1 mm EDTA and variable amounts of substrates in ethanol (1% (v/v) final concentration).SpecieskcatKmGSHKmCDNBkcat/KmGSHkcat/KmCDNBRef.s-1mmmm-1·s-1ScFv 2F32.2860.45542.2845.0201.001GST 3–3214.3 ± 0.74.82 ± 0.330.17 ± 0.0244.4171244.9725Benson A.M. Talalay P. Keen J.H. Jakoby W.B. Proc. Natl. Acad. Sci. U. S. A. 1977; 74: 158-162Crossref PubMed Scopus (156) Google ScholarGST 5–5250.2 ± 6.40.37 ± 0.081.65 ± 0.49672.95151.7225Benson A.M. Talalay P. Keen J.H. Jakoby W.B. Proc. Natl. Acad. Sci. U. S. A. 1977; 74: 158-162Crossref PubMed Scopus (156) Google ScholarGST6–6234.4 ± 2.41.75 ± 0.432.88 ± 0.37133.8281.3425Benson A.M. Talalay P. Keen J.H. Jakoby W.B. Proc. Natl. Acad. Sci. U. S. A. 1977; 74: 158-162Crossref PubMed Scopus (156) Google ScholarGST3–6217.9 ± 4.82.20 ± 0.270.86 ± 0.1999252.6925Benson A.M. Talalay P. Keen J.H. Jakoby W.B. Proc. Natl. Acad. Sci. U. S. A. 1977; 74: 158-162Crossref PubMed Scopus (156) Google ScholarLucilia GST53 ± 10.53 ± 0.0410.165 ± 0.00810032128Caccuri A.M. Antonini G. Nicotra M. Battistoni A. Lo Bello M. Board P.G. Parker M.W. Ricci G. J. Biol. Chem. 1997; 272: 29681-29686Abstract Full Text Full Text PDF PubMed Scopus (70) Google Scholar Open table in a new tab ScFv2F3 displays GST activity, indicating that in scFv2F3 there is an active site that could bind the substrates GSH and CDNB and has a catalytic group to catalyze the conjugation of GSH to CDNB. KmGSH and KmCDNB of scFv2F3 are close to those of some native GSTs, indicating scFv2F3 has strong affinities to both GSH and CDNB. Then, which amino acid residue is the catalytic residue of scFv2F3? The experimental result showed that when scFv2F3 was converted into Se-scFv2F3 by chemical mutation of hydroxyl groups in the Ser residues of scFv2F3, it lost all GST activities and gained a high GPX activity to CuOOH or H2O2 (6Ren X.J. Gao S.J. You D.L. Huang H.L. Liu Z. Mu Y. Liu J.Q. Zhang Y. Yan G.L. Luo G.M. Yang T.S. Shen J.C. Biochem. J. 2001; 359: 369-374Crossref PubMed Google Scholar), indicating that Ser in scFv2F3 could greatly contribute to GPX activity (4Ren X.J. Jemth P. Board P.G. Luo G.M. Mannervik B. Liu J.Q. Zhang K. Shen J.C. Chem. Biol. 2002; 9: 789-794Abstract Full Text Full Text PDF PubMed Scopus (49) Google Scholar). Therefore, some Ser in scFv2F3 is the residue that can catalyze conjugation of GSH to electrophilic compounds. Moreover, according to the three-dimensional structure of Se-scFv2F3 built by means of homology modeling, the chemical modification site of scFv2F3 is SerH52, and a hydrogen bond can be formed between the selenol group of the modified SerH52 and the sulfhydryl group of GSH (18Zhang Y. Li Z.S. Sun M. Zheng Q.C. Sun C.C. Biochim. Biophys. Acta. 2005; 1747: 27-34Crossref PubMed Scopus (12) Google Scholar). That is, the hydroxyl of the SerH52 is juxtaposed to the sulfhydryl group of GSH, and a certain chemical reaction can occur between them. Therefore, the 52nd amino acid residue is the catalytic residue of scFv2F3. Whether scFv2F3 exhibits GST or GPX activity depends on whether oxygen or selenium is present in the side chain of the 52nd amino acid residue. The difference of only one atom led to the conversion of biological activities of scFv2F3, which suggests that GST and GPX are consanguineous. In previous studies, it has been proposed that GST and GPX have a “glutathione-binding protein” ancestor based on the similarities in their overall structures and the positioning of their important active site residues despite their functional differences and low sequence identity (14Armstrong R.N. Chem. Res. Toxicol. 1997; 10: 2-18Crossref PubMed Scopus (963) Google Scholar, 29Martin J.L. Structure. 1995; 3: 245-250Abstract Full Text Full Text PDF PubMed Scopus (693) Google Scholar). Considering the mechanism of seleno-protein synthesis in organisms (30Jiang Z.H. Mu Y. Li W.J. Yan G.L. Luo G.M. Acta Biochim. Biophys. Sin. 2002; 34: 395-399Google Scholar, 31Stadtman T.C. Annu. Rev. Biochem. 1996; 65: 83-100Crossref PubMed Scopus (814) Google Scholar, 32Atkins J.F. Gesteland R.F. Nature. 2000; 407: 463-465Crossref PubMed Scopus (107) Google Scholar, 33Hatfield D.L. Gladyshev V.N. Mol. Cell. Biol. 2002; 22: 3565-3576Crossref PubMed Scopus (544) Google Scholar, 34Thambichler M. Böck A. Methods Enzymol. 2002; 347: 3-16Crossref PubMed Scopus (29) Google Scholar), it is very possible that they evolved from the same ancestor and separately developed different functions to accommodate to the constantly changing environment. From Table 3, we can see that the changes in substrate concentrations have almost no effect on the Km of substrates, indicating that the affinities of scFv2F3 to GSH and CDNB changed little and the structure of the scFv2F3 active site cannot change flexibly. Therefore, the kcat/Km of one substrate increased as the concentration of another substrate increased. Because kcat/Km means the selectivity of enzyme to substrate, the higher the CDNB concentration the stronger the selectivity of scFv2F3 to GSH and vice versa. KmGSH is less than KmCDNB, so scFv2F3 shows better selectivity to GSH than to CDNB when their concentrations are the same. From Table 5, we can see that the kcat of scFv2F3 is very low. Even compared with that of Lucilia GST whose catalytic residue is serine, it is one order of magnitude lower. This mainly results from the high structure similarity between hapten GSH-S-DN2phBu and the product of GSH conjugated with CDNB (Fig. 4). Because scFv2F3 was cloned from monoclonal antibody 2F3, which was elicited against hapten GSH-S-DN2phBu, scFv2F3 has a strong affinity to GSH-S-DN2phBu. Because the structure of the product of GSH conjugated with CDNB has only a small difference from that of GSH-S-DN2phBu, scFv2F3 can bind the product too strongly to release from it. Therefore, the reaction velocity is delayed, and the kcat of scFv2F3 catalyzing GSH conjugated to CDNB is low. The process of an enzymatic reaction usually is divided in three steps: binding its substrate, catalytic reaction, and releasing its product. A naturally occurring enzyme, after a long period of evolution, has formed a fine and ingenious system to accomplish catalysis. When an enzyme binds its substrate, its active site shape changes to create a shape into which the substrate fits. In the same way, the shape of the active site changes to release the product as soon as the product is produced. The rapid change of the shape of the active site ensures that an enzyme can bind the substrate and release the product continuously, which endows enzymes with great catalytic efficiency. However, most mimics are not as dynamic and flexible as native enzymes and do not have such a perfect system to recognize substrates and products. In particular, the shape of the active site of mimic cannot change continuously to bind its substrate and release its product. In this experiment, the binding site of scFv2F3 induced by hapten GSH-S-DN2phBu has strong affinities to the two substrates and makes their active groups adjacent in space, which is advantageous to the conjugate reaction. In addition, fortunately there is a Ser as the catalytic residue of scFv2F3, which is juxtaposed to the sulfhydryl group of GSH. Therefore, scFv2F3 exhibits GST activities. This result indicates that our approach on imitating enzymes is correct. However, the catalytic capability of scFv2F3 and Se-scFv2F3 are much different, though the only difference between them is their catalytic groups. The GST activities of scFv2F3 are not high. On the contrary, Se-scFv2F3 showed a very high GPX activity, even much higher than native GPX from rabbit liver (6Ren X.J. Gao S.J. You D.L. Huang H.L. Liu Z. Mu Y. Liu J.Q. Zhang Y. Yan G.L. Luo G.M. Yang T.S. Shen J.C. Biochem. J. 2001; 359: 369-374Crossref PubMed Google Scholar). The reasons are that GSH-S-DN2phBu and the reaction product of GSH and CDNB are very similar and scFv2F3 binds the product too tightly to release it rapidly. However, neither the substrates nor the products in the reaction Se-scFv2F3 catalyzed are as similar as those in the reaction scFv2F3 catalyzed to GSH-S-DN2phBu; in the active site there is enough room for the substrates entering and the products leaving, which improves the catalytic velocity. Therefore, it is important to consider product inhibition in hapten design in order to obtain an abzyme with a highly catalytic efficiency. Considering the affinity of antibody to antigen and the structure rigidity of abzymes, when we design a hapten to elicit a catalytic antibody we should consider not only its affinity to its substrate but also its dissociation with its product. By hapten redesign, a bigger active site could be obtained that will provide more room for product leaving from it to avoid product inhibition." @default.
• W2029683890 created "2016-06-24" @default.
• W2029683890 creator A5011151098 @default.
• W2029683890 creator A5016150985 @default.
• W2029683890 creator A5027528821 @default.
• W2029683890 creator A5029187604 @default.
• W2029683890 creator A5049588474 @default.
• W2029683890 creator A5051000940 @default.
• W2029683890 creator A5067513899 @default.
• W2029683890 creator A5079435141 @default.
• W2029683890 date "2006-05-01" @default.
• W2029683890 modified "2023-10-15" @default.
• W2029683890 title "Single Chain Antibody Displays Glutathione S-Transferase Activity" @default.
• W2029683890 cites W1492410262 @default.
• W2029683890 cites W1528266879 @default.
• W2029683890 cites W1536923222 @default.
• W2029683890 cites W1563520923 @default.
• W2029683890 cites W1572376186 @default.
• W2029683890 cites W1775749144 @default.
• W2029683890 cites W1792325685 @default.
• W2029683890 cites W1831825906 @default.
• W2029683890 cites W1972702872 @default.
• W2029683890 cites W1974534158 @default.
• W2029683890 cites W1987046754 @default.
• W2029683890 cites W1990954379 @default.
• W2029683890 cites W1996425316 @default.
• W2029683890 cites W2010131959 @default.
• W2029683890 cites W2011837287 @default.
• W2029683890 cites W2014321676 @default.
• W2029683890 cites W2017727291 @default.
• W2029683890 cites W2017842855 @default.
• W2029683890 cites W2029811175 @default.
• W2029683890 cites W2045535388 @default.
• W2029683890 cites W2047804693 @default.
• W2029683890 cites W2067192143 @default.
• W2029683890 cites W2071195046 @default.
• W2029683890 cites W2073517578 @default.
• W2029683890 cites W2074461690 @default.
• W2029683890 cites W2098890352 @default.
• W2029683890 cites W2128553657 @default.
• W2029683890 cites W245556384 @default.
• W2029683890 cites W4231680606 @default.
• W2029683890 cites W4237698093 @default.
• W2029683890 cites W4251440173 @default.
• W2029683890 cites W4256195141 @default.
• W2029683890 doi "https://doi.org/10.1074/jbc.m513596200" @default.
• W2029683890 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16507568" @default.
• W2029683890 hasPublicationYear "2006" @default.
• W2029683890 type Work @default.
• W2029683890 sameAs 2029683890 @default.
• W2029683890 citedByCount "13" @default.
• W2029683890 countsByYear W20296838902012 @default.
• W2029683890 countsByYear W20296838902014 @default.
• W2029683890 countsByYear W20296838902017 @default.
• W2029683890 countsByYear W20296838902018 @default.
• W2029683890 countsByYear W20296838902022 @default.
• W2029683890 crossrefType "journal-article" @default.
• W2029683890 hasAuthorship W2029683890A5011151098 @default.
• W2029683890 hasAuthorship W2029683890A5016150985 @default.
• W2029683890 hasAuthorship W2029683890A5027528821 @default.
• W2029683890 hasAuthorship W2029683890A5029187604 @default.
• W2029683890 hasAuthorship W2029683890A5049588474 @default.
• W2029683890 hasAuthorship W2029683890A5051000940 @default.
• W2029683890 hasAuthorship W2029683890A5067513899 @default.
• W2029683890 hasAuthorship W2029683890A5079435141 @default.
• W2029683890 hasBestOaLocation W20296838901 @default.
• W2029683890 hasConcept C153911025 @default.
• W2029683890 hasConcept C159654299 @default.
• W2029683890 hasConcept C181199279 @default.
• W2029683890 hasConcept C185592680 @default.
• W2029683890 hasConcept C2776376580 @default.
• W2029683890 hasConcept C2776907368 @default.
• W2029683890 hasConcept C3019047270 @default.
• W2029683890 hasConcept C538909803 @default.
• W2029683890 hasConcept C54355233 @default.
• W2029683890 hasConcept C55493867 @default.
• W2029683890 hasConcept C86803240 @default.
• W2029683890 hasConceptScore W2029683890C153911025 @default.
• W2029683890 hasConceptScore W2029683890C159654299 @default.
• W2029683890 hasConceptScore W2029683890C181199279 @default.
• W2029683890 hasConceptScore W2029683890C185592680 @default.
• W2029683890 hasConceptScore W2029683890C2776376580 @default.
• W2029683890 hasConceptScore W2029683890C2776907368 @default.
• W2029683890 hasConceptScore W2029683890C3019047270 @default.
• W2029683890 hasConceptScore W2029683890C538909803 @default.
• W2029683890 hasConceptScore W2029683890C54355233 @default.
• W2029683890 hasConceptScore W2029683890C55493867 @default.
• W2029683890 hasConceptScore W2029683890C86803240 @default.
• W2029683890 hasIssue "18" @default.
• W2029683890 hasLocation W20296838901 @default.
• W2029683890 hasOpenAccess W2029683890 @default.
• W2029683890 hasPrimaryLocation W20296838901 @default.
• W2029683890 hasRelatedWork W1769442777 @default.
• W2029683890 hasRelatedWork W1972928594 @default.
• W2029683890 hasRelatedWork W2028213226 @default.
• W2029683890 hasRelatedWork W2077452431 @default.
• W2029683890 hasRelatedWork W2079089358 @default.
• W2029683890 hasRelatedWork W2090015674 @default.

• next